Milford, MA, United States of America

Evan Barry

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evan Barry. Retrieved from https://idiyas.com/inventor/evan-barry-oab3dqh9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Evan Barry

Introduction

Evan Barry is a notable inventor based in Milford, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment of neoplastic disorders. His work focuses on innovative methods that have the potential to impact patient care positively.

Latest Patents

Evan Barry holds 1 patent for his invention titled "Methods of using splicing modulators." This patent relates to methods for treating neoplastic disorders by administering Compound 1, or a pharmaceutically acceptable salt thereof, either on its own or as part of a conjugate or composition. The invention aims to induce the production of at least one neoantigen, which could play a crucial role in cancer treatment.

Career Highlights

Evan Barry is currently employed at Eisai R&D Management Co., Ltd., where he continues to develop and refine his innovative ideas. His work at this esteemed organization allows him to collaborate with other talented professionals in the field.

Collaborations

Evan has worked alongside notable colleagues such as Ermira Pazolli and Silvia Buonamici. Their combined expertise contributes to the advancement of research and development in their respective areas.

Conclusion

Evan Barry's contributions to the field of medical research through his innovative patent demonstrate his commitment to improving treatment options for neoplastic disorders. His work continues to inspire advancements in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…